DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
14/04/2021 - 5 minutes
Allergy
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
08/05/2019 - 7 minutes
Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
18/03/2019 - 2 minutes
Inflammatory Disease Treatment Backed by €20M Series A
The Swiss company Calypso Biotech has raised a sizeable €20M to fund its immunotherapy for…
20/02/2019 - 2 minutes
This Hypoallergenic Vaccine Could Alleviate Hay Fever Faster Than Approved Vaccines
We decided to make a visit to Espoo, Finland, this week, to visit Desentum. The…
07/12/2018 - 4 minutes
This Immunotherapy Could Be The First to Treat Milk Allergy in Children
DBV Technologies has shown in a Phase II trial that its skin patch could desensitize…
29/05/2018 - 2 minutes
Positive House Dust Mite Immunotherapy Results for UK Biotech
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
29/05/2018 - 1 minute
Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
23/05/2018 - 2 minutes
DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial
DBV Technologies' candidate could be the first treatment for allergies to cow milk after its…
27/02/2018 - 3 minutes
ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies
ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to…
26/02/2018 - 3 minutes
After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy
DBV Technologies has positive safety data supporting the approval of a treatment for peanut allergy…
20/11/2017 - 2 minutes
Peanut Allergy Trial Fails but French Biotech Keeps Pushing for Approval
DBV Technologies plans to go ahead with its peanut allergy treatment despite its failure to…
23/10/2017 - 2 minutes
